SCLX Q4 2022 Earnings — Scilex Holding Company Revenue & Financial Results | Market Cap Arena

SCLXScilex Holding Company

$73M

Q4 2022 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$12M+44.2% YoY

Gross Profit

$7M62.1% margin

Operating Income

-$20M-165.6% margin

Net Income

-$18M-150.0% margin

EPS (Diluted)

$-0.16

QoQ Revenue Growth

+4.8%

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$19M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$87M

Total Liabilities

$50M

Stockholders' Equity

$36M

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$12M	$8M	+44.2%
Gross Profit	$7M	$7M	+3.2%
Operating Income	-$20M	-$10M	-89.5%
Net Income	-$18M	-$42M	+57.4%